0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Long-acting depot formulations of naltrexone for heroin dependence: a review.

      Current Opinion in Psychiatry

      Medication Adherence, administration & dosage, Heroin Dependence, Delayed-Action Preparations, Humans, adverse effects, Injections, Intramuscular, psychology, Naltrexone, Narcotic Antagonists, Drug Implants, Secondary Prevention, rehabilitation

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The major problem with the oral formulation of naltrexone for heroin dependence is poor compliance (adherence). Long-acting sustained release formulations of naltrexone (implantable and injectable) might help to improve compliance and, thus, increase the efficacy of abstinence-oriented treatment of heroin dependence with naltrexone. There have been several implantable and injectable formulations of naltrexone developed within the last decade. It was demonstrated that some of them are effective and relatively well tolerated medications for relapse prevention in heroin addicts. However, advantages and disadvantages of these new medications have never been systematically analyzed. Long-acting sustained release formulations of naltrexone are well tolerated and more effective for relapse prevention in heroin addicts than the oral ones.

          Related collections

          Author and article information

          Journal
          20224403
          10.1097/YCO.0b013e3283386578

          Comments

          Comment on this article